Article Versions Notes

Zoga E, Wolff R, Ackermann H, Meissner M, Rödel C, Tselis N, Chatzikonstantinou G. Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies. Cancers. 2022; 14(10):2391. https://doi.org/10.3390/cancers14102391

Zoga, Eleni, Robert Wolff, Hanns Ackermann, Markus Meissner, Claus Rödel, Nikolaos Tselis, and Georgios Chatzikonstantinou. 2022. "Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies" Cancers 14, no. 10: 2391. https://doi.org/10.3390/cancers14102391

Zoga, E., Wolff, R., Ackermann, H., Meissner, M., Rödel, C., Tselis, N., & Chatzikonstantinou, G. (2022). Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies. Cancers, 14(10), 2391. https://doi.org/10.3390/cancers14102391